Hdl Handle:
http://hdl.handle.net/10147/270515
Title:
Rosuvastatin-induced pemphigoid.
Authors:
Murad, Aizuri A; Connolly, Maureen; Tobin, Anne-Marie
Affiliation:
Dermatology Department, Adelaide and Meath Hospital, Dublin, Ireland. aiz100@hotmail.com
Citation:
Rosuvastatin-induced pemphigoid. 2012, 2012: BMJ Case Rep
Journal:
BMJ case reports
Issue Date:
2012
URI:
http://hdl.handle.net/10147/270515
DOI:
10.1136/bcr.11.2011.5180
PubMed ID:
22605857
Abstract:
Statins are widely prescribed medications and very well tolerated. Rosuvastatin is another member of this drug used to treat dyslipidaemia. It is a competitive inhibitor of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase. Immunobullous disease is usually idiopathic but can be drug-induced. Both idiopathic and iatrogenic forms share common clinical and immunohistological features. The authors report a case of pemphigoid induced by rosuvastatin, a commonly prescribed medication. To our knowledge, there is limited report on rosuvastatin associated with pemphigoid in the literature.
Item Type:
Article
Language:
en
MeSH:
Biopsy; Dyslipidemias; Female; Fluorescent Antibody Technique; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Pemphigoid, Bullous; Pyrimidines; Sulfonamides
ISSN:
1757-790X

Full metadata record

DC FieldValue Language
dc.contributor.authorMurad, Aizuri Aen_GB
dc.contributor.authorConnolly, Maureenen_GB
dc.contributor.authorTobin, Anne-Marieen_GB
dc.date.accessioned2013-02-26T16:24:58Z-
dc.date.available2013-02-26T16:24:58Z-
dc.date.issued2012-
dc.identifier.citationRosuvastatin-induced pemphigoid. 2012, 2012: BMJ Case Repen_GB
dc.identifier.issn1757-790X-
dc.identifier.pmid22605857-
dc.identifier.doi10.1136/bcr.11.2011.5180-
dc.identifier.urihttp://hdl.handle.net/10147/270515-
dc.description.abstractStatins are widely prescribed medications and very well tolerated. Rosuvastatin is another member of this drug used to treat dyslipidaemia. It is a competitive inhibitor of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase. Immunobullous disease is usually idiopathic but can be drug-induced. Both idiopathic and iatrogenic forms share common clinical and immunohistological features. The authors report a case of pemphigoid induced by rosuvastatin, a commonly prescribed medication. To our knowledge, there is limited report on rosuvastatin associated with pemphigoid in the literature.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to BMJ case reportsen_GB
dc.subject.meshBiopsy-
dc.subject.meshDyslipidemias-
dc.subject.meshFemale-
dc.subject.meshFluorescent Antibody Technique-
dc.subject.meshFluorobenzenes-
dc.subject.meshHumans-
dc.subject.meshHydroxymethylglutaryl-CoA Reductase Inhibitors-
dc.subject.meshMiddle Aged-
dc.subject.meshPemphigoid, Bullous-
dc.subject.meshPyrimidines-
dc.subject.meshSulfonamides-
dc.titleRosuvastatin-induced pemphigoid.en_GB
dc.typeArticleen
dc.contributor.departmentDermatology Department, Adelaide and Meath Hospital, Dublin, Ireland. aiz100@hotmail.comen_GB
dc.identifier.journalBMJ case reportsen_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.